Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Jump to content

Velagliflozin

From Wikipedia, the free encyclopedia

Velagliflozin
Clinical data
Trade namesSenvelgo
License data
Routes of
administration		By mouth
ATCvet code
Legal status
Legal status
Identifiers
  • 2-[(4-cyclopropylphenyl)methyl]-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzonitrile
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H25NO5
Molar mass395.455 g·mol−1
3D model (JSmol)
  • C1CC1C2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C#N
  • InChI=1S/C23H25NO5/c24-11-17-8-7-16(23-22(28)21(27)20(26)19(12-25)29-23)10-18(17)9-13-1-3-14(4-2-13)15-5-6-15/h1-4,7-8,10,15,19-23,25-28H,5-6,9,12H2/t19-,20-,21+,22-,23+/m1/s1
  • Key:SENUNDCNOYAWGN-ZQGJOIPISA-N
  • Key:UWKBFNWQMSGEPG-ZHNCTCHCSA-N

Velagliflozin, sold under the brand name Senvelgo, is an antidiabetic medication used for the treatment of cats.[1][2] Velagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.[3] It is taken by mouth.[1]

Medical uses[edit]

Velagliflozin is indicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.[1][2][3]

References[edit]

  1. ^ a b c d "Senvelgo- velagliflozin solution". DailyMed. 8 November 2023. Retrieved 13 December 2023.
  2. ^ a b https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14320 Public Domain This article incorporates text from this source, which is in the public domain.
  3. ^ a b This article incorporates text from this source, which is in the public domain.


Stub icon

This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Velagliflozin&oldid=1202549921"